deputy director of vgnki delivered a REPORT at the exhibition Pharmtech & Ingredients – 2025
From November 25 to 28 of this year, an exhibition of equipment, raw materials, and technologies for pharmaceutical production Pharmtech & Ingredients – 2025, significant for both Russia and the EAEU countries, takes place in Moscow. This sector-specific event traditionally brings together technology leaders and specialists interested in selection of production solutions of pharmaceutical products and veterinary medicines.
On November 25, during business program, Vasilina Gritsiuk, the Deputy Director of the Russian State Centre for Animal Feed and Drug Standardization and Quality (VGNKI), delivered a report on major mistakes in medicinal products registration.
At the round table “From Import Substitution to Technological Leadership. New Challenges for the Russian Veterinary Pharmaceuticals”, Vasilina Gritsiuk presented current data. She noted that 103 veterinary medicines were registered in 2025, with 51 intended for pets, 48 – for farm animals, and 4 – for both pets and farm animals. In addition, the comparative analysis of performance of state assignment by VGNKI in medicinal product evaluation was also presented. In particular, 150 evaluations were carried out in 2024 under registration procedure, 20 of which related to immunobiologicals of domestic manufacture.
The speaker made a special point of discussing the legal aspects, noting in particular that the Regulation of the Government of the Russian Federation No. 353, dated March 12, 2022 sets forth an expedited regime for the state registration procedure not exceeding 60 working days and remaining effective until December 31, 2025 for domestic veterinary medicinal products manufactured as a part of import substitution efforts. Furthermore, after completing the expedited registration, the manufacturer shall forward to VGNKI samples of first two batches of medicinal product.
In the main part of the speech, typical mistakes of manufacturers were discussed. Particularly, it was noted that companies sometimes forget to provide samples required for two tests and instead send two batches of medicines directly for release into civil circulation. Other common issues include the submission of insufficient sample volumes for full analytical control, the need to revise registration methods, and improper packaging of medicines for testing purposes.
In the final part of her speech, Vasilina Gritsiuk emphasized that for the last 4-5 years the Russian veterinary pharmaceuticals demonstrates stable growth. Whereas previously the main focus was on antibacterial agents, now other areas are actively developing: anti-inflammatory medicines, hormonal preparations, detoxification compositions, sedatives, diuretics, and antiemetics.
